news_6

Mirum Pharmaceuticals and GC Pharma Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Liver Diseases in South Korea

- GC Pharma to lead development and commercialization in South Korea - Mirum seeks to expand global availability of maralixibat...

news_6

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages 360 DigiTech, Inc. Investors with Losses Over $100K to Secure Counsel Before Important September 13 Deadline in Securities Class Action – QFIN

news_6

Adagio Therapeutics Partners with Biocon Biologics to Bring Potent and Broadly Neutralizing COVID-19 Antibody Treatment to Patients in India and Select Emerging Markets

WALTHAM, Mass.--(BUSINESS WIRE)--Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for...